Term: golimumab
IPA: ɡoʊˈlɪm.jəˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en||-lim-|-umab|t2=immunomodulating|t3=human monoclonal antibody}}.

{{rfe|en}}

===Pronunciation===
* {{IPA|en|/ɡoʊˈlɪm.jəˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} A [[genetically engineered]] [[monoclonal antibody]] (trademark '''[[Simponi]]''') that inhibits the activity of {{w|tumor necrosis factor}} and is administered by {{w|subcutaneous injection}} to treat [[rheumatoid arthritis]], {{w|psoriatic arthritis}}, {{w|